Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study.

about

Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study.

Item

http://www.wikidata.org/entity/Q55162071

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Safety of Intravenous Immunogl ...... se: Results of a French Study.

@en

Safety of Intravenous Immunogl ...... se: Results of a French Study.

@nl

type

Item

label

Safety of Intravenous Immunogl ...... se: Results of a French Study.

@en

Safety of Intravenous Immunogl ...... se: Results of a French Study.

@nl

prefLabel

Safety of Intravenous Immunogl ...... se: Results of a French Study.

@en

Safety of Intravenous Immunogl ...... se: Results of a French Study.

@nl

P1476

Safety of Intravenous Immunogl ...... ase: Results of a French Study

@en

P2093

Alain Créange

http://www.w3.org/2001/XMLSchema#string

Claude Desnuelle

http://www.w3.org/2001/XMLSchema#string

François Rouhart

http://www.w3.org/2001/XMLSchema#string

François Ziegler

http://www.w3.org/2001/XMLSchema#string

Françoise Bouhour

http://www.w3.org/2001/XMLSchema#string

Guilhem Solé

http://www.w3.org/2001/XMLSchema#string

Gwendal Le Masson

http://www.w3.org/2001/XMLSchema#string

Gérard Besson

http://www.w3.org/2001/XMLSchema#string

Jean-Christophe Antoine

http://www.w3.org/2001/XMLSchema#string

Jean-Michel Paquet

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe

Use of intravenous immunoglobulin G (IVIG).

Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.

Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.

Safety of liquid intravenous immunoglobulin for neuroimmunologic disorders in the home setting: a retrospective analysis of 1085 infusions.

The safety profile of home infusion of intravenous immunoglobulin in patients with neuroimmunologic disorders.

Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

New insights into the management of chronic inflammatory demyelinating polyradiculoneuropathy.

P304

8147251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/8147251

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29736397

http://www.w3.org/2001/XMLSchema#string

P932

5875056

http://www.w3.org/2001/XMLSchema#string